NovoLog Mix 70/30 100 [iU]/mL

NovoLog Mix 70/30 100 [iU]/mL is a pre-mixed insulin aspart suspension for subcutaneous injection. It combines rapid-acting and intermediate-acting insulin to help manage blood glucose levels in diabetes care. This Novo Nordisk product is designed for convenient use with a 10 mL glass vial.

NovoLog Mix 70/30 100 [iU]/mL is primarily used for managing blood sugar levels in adults with diabetes. This insulin aspart suspension is formulated to provide both rapid and intermediate-acting insulin effects, supporting glucose control throughout the day. It is often prescribed for individuals who require a pre-mixed insulin regimen to simplify their diabetes management routine.

When used as directed, NovoLog Mix 70/30 100 [iU]/mL may help lower blood sugar levels by enhancing the body's natural insulin response. Some users may experience common effects such as mild injection site reactions or changes in blood sugar levels. It is important to monitor blood glucose regularly while using this medication.

NovoLog Mix 70/30 100 [iU]/mL should be stored properly to maintain its effectiveness. Keep the vial refrigerated and protect it from light and heat. Always check the expiration date before use. Consult a healthcare provider before starting or adjusting any insulin regimen, especially if you have a history of low blood sugar or other medical conditions.

NovoLog Mix 70/30 100 [iU]/mL may interact with other medications, including oral hypoglycemic agents, beta-blockers, and corticosteroids. Alcohol consumption can also affect blood sugar levels and should be monitored carefully. Always inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.